|
시장보고서
상품코드
1338867
다이어트 필 시장 점유율, 규모, 동향, 산업 분석 보고서 : 제품 유형별, 유통 채널별, 용도별, 지역별, 부문별 예측(2023-2032년)Diet Pills Market Share, Size, Trends, Industry Analysis Report, By Product Type (Prescription Based Drugs, Over the Counter Drugs, and Herbal Supplements); By Distribution Channel; By Application; By Region; Segment Forecast, 2023-2032 |
||||||
Polaris Market Research의 최신 연구에 따르면, 세계 다이어트 필 시장 규모는 2032년까지 33억 9,953만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
다이어트 필에 대한 수요는 정부의 비만 대책에 의해 촉진되고 있습니다. 불합리한 체중 증가, 당뇨병, 비만과 같은 문제의 확산은 다이어트 필의 판매를 증가시킬 것으로 예상됩니다. 미국 질병예방 및 건강증진국에 따르면 미국 어린이와 성인 5명 중 1명, 성인 5명 중 2명이 비만이며, 더 많은 사람들이 과체중이라고 합니다. Healthy People 2030의 목표는 건강한 식습관과 규칙적인 운동을 장려하여 건강한 체중을 유지할 수 있도록 하는 것이다, 심장병, 뇌졸중, 일부 암은 비만과 관련된 심각한 건강 문제 중 일부에 불과합니다. 영양 보충제 처방의 필요성에 대한 대중의 인식이 높아짐에 따라 이러한 보충제 섭취의 인기가 급증하고 있습니다.
최근 피트니스 애호가들이 다이어트 필 처방에서 영양사의 역할을 통제하고 있습니다. 다이어트 보조제 제조업체는 이러한 추세에 주목하고 전략적 마케팅에 주력하고 있습니다. 의학 연구 분야가 발전하고 있으며, 예측 기간 동안 다이어트 필에 대한 수요가 증가하고 있습니다. 여러 기업이 다양한 영양제를 성공적으로 시장에 출시했습니다. 예를 들어, 2021년 7월 미국 식품의약국(FDA)은 웨고비(리라글루티드) 주사제(2.4mg, 주 1회)를 비만 또는 체중 관련 장애(고콜레스테롤, 제2형 당뇨병 등)가 있는 성인에서 저칼로리 식단 및 신체 활동 강화와 함께 사용할 수 있도록 승인했습니다. 따라서 이러한 요인들이 시장 성장을 뒷받침하고 있습니다.
또한, 비처방 다이어트 필은 의사의 처방전 없이 구입하거나 사용할 수 있는 건강보조식품입니다. 이러한 보충제에 함유된 성분은 종종 신진대사를 촉진하고, 배고픔을 억제하고, 탄수화물과 지방의 흡수를 방지하여 체중 감량에 도움을 준다고 약속합니다. 카페인, 녹차 추출물, 크롬, 가르시니아 캄보지아, 푸디아골드니 등은 시중에서 판매되는 다이어트 필의 대표적인 성분입니다. 따라서 시중에서 판매되는 약품에 대한 수요가 증가하고 있습니다.
다이어트 필 시장 보고서 하이라이트
오프라인 분야는 조사 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 다이어트 필의 대면 판매는 일반적으로 소매점이나 병원 약국에서 이루어집니다.
허브 보충제 분야가 큰 수익 비중을 차지할 것입니다. 더 많은 비건 및 식물성 대체 식단에 대한 욕구가 호의적인 성장으로 이어질 것으로 보입니다.
아시아태평양은 소비자의 건강 의식 향상, 가처분 소득 증가, 인구 통계학적 변화로 인해 예측 기간 동안 큰 폭의 성장이 예상됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 다이어트 필 시장에 관한 인사이트
- 다이어트 필 시장 - 유통 채널 현황
- 다이어트 필 시장 역학
- 성장 촉진요인과 기회
- 비만 증가와 비만 우려
- 건강 인식 확산
- 성장 억제요인과 과제
- 부작용 걱정
- 성장 촉진요인과 기회
- PESTEL 분석
- 다이어트 필 시장 유통 채널 동향
- 밸류체인 분석
- COVID-19 감염증의 영향 분석
제5장 세계의 다이어트 필 시장, 제품 유형별
- 주요 조사 결과
- 서론
- 처방전 기반 의약품
- 시판약
- 허브 보충제
제6장 세계의 다이어트 필 시장, 용도별
- 주요 조사 결과
- 서론
- 대사 증진 필
- 지방 차단 필
- 식욕 조절 필
- 기타
제7장 세계의 다이어트 필 시장, 유통 채널별
- 주요 조사 결과
- 서론
- 병원 약국
- 드럭스토어
- 소매 약국
- 온라인 약국
제8장 세계의 다이어트 필 시장, 지역별
- 주요 조사 결과
- 서론
- 다이어트 필 시장 평가, 지역별, 2019-2032년
- 다이어트 필 시장 - 북미
- 북미 : 다이어트 필 시장, 제품 유형별, 2019-2032년
- 북미 : 다이어트 필 시장, 유통 채널별, 2019-2032년
- 북미 : 다이어트 필 시장, 용도별, 2019-2032년
- 다이어트 필 시장 - 미국
- 다이어트 필 시장 - 캐나다
- 다이어트 필 시장 - 유럽
- 유럽 : 다이어트 필 시장, 제품 유형별, 2019-2032년
- 유럽 : 다이어트 필 시장, 유통 채널별, 2019-2032년
- 유럽 : 다이어트 필 시장, 용도별, 2019-2032년
- 다이어트 필 시장 - 영국
- 다이어트 필 시장 - 프랑스
- 다이어트 필 시장 - 독일
- 다이어트 필 시장 - 이탈리아
- 다이어트 필 시장 - 스페인
- 다이어트 필 시장 - 네델란드
- 다이어트 필 시장 - 러시아
- 다이어트 필 시장 - 아시아태평양
- 아시아태평양 : 다이어트 필 시장, 제품 유형별, 2019-2032년
- 아시아태평양 : 다이어트 필 시장, 유통 채널별, 2019-2032년
- 아시아태평양 : 다이어트 필 시장, 용도별, 2019-2032년
- 다이어트 필 시장 - 중국
- 다이어트 필 시장 - 인도
- 다이어트 필 시장 - 말레이시아
- 다이어트 필 시장 - 일본
- 다이어트 필 시장 - 인도네시아
- 다이어트 필 시장 - 한국
- 다이어트 필 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 다이어트 필 시장, 제품 유형별, 2019-2032년
- 중동 및 아프리카 : 다이어트 필 시장, 유통 채널별, 2019-2032년
- 중동 및 아프리카 : 다이어트 필 시장, 용도별, 2019-2032년
- 다이어트 필 시장 - 사우디아라비아
- 다이어트 필 시장 - 아랍에미리트
- 다이어트 필 시장 - 이스라엘
- 다이어트 필 시장 - 남아프리카공화국
- 다이어트 필 시장 - 라틴아메리카
- 라틴아메리카 : 다이어트 필 시장, 제품 유형별, 2019-2032년
- 라틴아메리카 : 다이어트 필 시장, 유통 채널별, 2019-2032년
- 라틴아메리카 : 다이어트 필 시장, 용도별, 2019-2032년
- 다이어트 필 시장 - 멕시코
- 다이어트 필 시장 - 브라질
- 다이어트 필 시장 - 아르헨티나
제9장 경쟁 상황
- 확장과 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Arena Pharmaceuticals
- Currax Pharmaceuticals
- Chong's Health Care
- Cortislim
- Gelesis Inc
- GlaxoSmithKline Pharmaceuticals
- Lovate Health Sciences
- Novo Nordisk
- Nanjing Chang'ao Pharmaceutical
- Orexigen Therapeutics
- Pfizer Inc
- TEVA Pharmaceutical
- Vivus, Inc
- Zoller Laboratories
The global diet pills market size is expected to reach USD 3,399.53 million by 2032, according to a new study by Polaris Market Research. The report "Diet Pills Market Share, Size, Trends, Industry Analysis Report, By Product Type (Prescription Based Drugs, Over the Counter Drugs, and Herbal Supplements); By Distribution Channel; By Application; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Diet pill demand is being fueled by government measures to combat obesity. The prevalence of issues, including irrational weight gain, diabetes, and obesity, is anticipated to boost sales of diet pills. According to the Office of Disease Prevention and Health Promotion, In the United States, 1 in 5 children and adults and 2 in 5 adults are obese, while many more are overweight. The goal of Healthy People 2030 is to encourage healthy eating and regular exercise so that people can achieve and keep a healthy weight. Type 2 diabetes, heart conditions, stroke, and some cancers are just a few of the significant health issues that obesity is associated with. The public is becoming more aware of the need for prescriptions for dietary supplements, and there is a spike in the popularity of consuming these supplements.
Nowadays, fitness enthusiasts control nutritionists' role in the prescription of diet medications. Diet pill manufacturers frequently pay some attention to these trends and place a greater emphasis on their goods' strategic marketing. The medical research field is developing, causing the demand for diet pills to increase over the forecast period. Several businesses have successfully introduced a variety of nutritional pills on the market. For instance, in July 2021, Wegovy (liraglutide) injection (2.4 mg once weekly) was approved by the U.S. Food and Drug Administration to be used in conjunction with a low-calorie diet and enhanced physical activity in adult people who are obese or weight-related disorder (such as high cholesterol, type 2 diabetes). Thus, these factors are supporting the growth of the market.
Additionally, non-prescription diet pills are dietary supplements that can be purchased or used without a prescription from a doctor. The components in these supplements frequently promise to aid in weight loss by boosting metabolism, reducing hunger, or preventing the absorption of carbohydrates or fats. Caffeine, green tea extract, chromium, garcinia cambogia, and hoodia gordonii are typical components in over-the-counter diet pills. Therefore, the demand for over-the-counter pills is rising.
Diet Pills Market Report Highlights
The offline segment is projected to grow at a highest CAGR over the study period. In-person sales of diet tablets typically take place in retail establishments and hospital pharmacies.
Herbal supplements segment accounted for significant revenue share. The desire for even more vegan and plant-based diet alternatives is likely to lead to favorable growth.
Asia-Pacific is expected to grow at a significant rate over the projected period due to increasing health consciousness among consumers, increasing disposable income, and demographic changes.
The global players include: Arena Pharmaceuticals, Currax Pharmaceuticals, Chong's Health Care, Cortislim, Novo Nordisk, Nanjing Chang'ao Pharmaceutical, Orexigen Therapeutics, TEVA Pharmaceutical, Vivus, Inc., & Zoller Laboratories
Polaris Market Research has segmented the Diet Pills market report based on product type, application, distribution channel, and region:
Diet Pills, Product Type Outlook (Revenue - USD Million, 2019 - 2032)
- Prescription Based Drugs
- Over the Counter Drugs
- Herbal Supplements
Diet Pills, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Metabolism Raising Pills
- Fat Blocking Pills
- Appetite Controlling Pills
- Others
Diet Pills, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)
- Offline Pharmacy
- Hospital Pharmacy
- Drug Stores
- Retails Pharmacy
- Online Pharmacy
Diet Pills, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Diet Pills Market Insights
- 4.1. Diet Pills Market - Distribution Channel Snapshot
- 4.2. Diet Pills Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising prevalence and worries about obesity
- 4.2.1.2. Growing health consciousness
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Concern about side effects
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Diet Pills Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Diet Pills Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 5.3. Prescription Based Drugs
- 5.3.1. Global Diet Pills Market, by Prescription Based Drugs, by Region, 2019-2032 (USD Million)
- 5.4. Over the Counter Drugs
- 5.4.1. Global Diet Pills Market, by Over the Counter Drugs, by Region, 2019-2032 (USD Million)
- 5.5. Herbal Supplements
- 5.5.1. Global Diet Pills Market, by Herbal Supplements, by Region, 2019-2032 (USD Million)
6. Global Diet Pills Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Diet Pills Market, by Application, 2019-2032 (USD Million)
- 6.3. Metabolism Raising Pills
- 6.3.1. Global Diet Pills Market, by Metabolism Raising Pills, by Region, 2019-2032 (USD Million)
- 6.4. Fat Blocking Pills
- 6.4.1. Global Diet Pills Market, by Fat Blocking Pills, by Region, 2019-2032 (USD Million)
- 6.5. Appetite Controlling Pills
- 6.5.1. Global Diet Pills Market, by Appetite Controlling Pills, by Region, 2019-2032 (USD Million)
- 6.6. Others
- 6.6.1. Global Diet Pills Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Diet Pills Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3. Hospital Pharmacy
- 7.3.1. Global Diet Pills Market, by Hospital Pharmacy, By Region, 2019-2032 (USD Million)
- 7.4. Drug Stores
- 7.4.1. Global Diet Pills Market, by Drug Stores, By Region, 2019-2032 (USD Million)
- 7.5. Retails Pharmacy
- 7.5.1. Global Diet Pills Market, by Retails Pharmacy, By Region, 2019-2032 (USD Million)
- 7.6. Online Pharmacy
- 7.6.1. Global Diet Pills Market, by Online Pharmacy, By Region, 2019-2032 (USD Million)
8. Global Diet Pills Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Diet Pills Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Diet Pills Market - North America
- 8.3.1. North America: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.3.2. North America: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.3. North America: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.3.4. Diet Pills Market - U.S.
- 8.3.4.1. U.S.: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.3.5. Diet Pills Market - Canada
- 8.3.5.1. Canada: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4. Diet Pills Market - Europe
- 8.4.1. Europe: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.3. Europe: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.4. Diet Pills Market - UK
- 8.4.4.1. UK: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.4.3. UK: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.5. Diet Pills Market - France
- 8.4.5.1. France: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.5.3. France: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.6. Diet Pills Market - Germany
- 8.4.6.1. Germany: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.7. Diet Pills Market - Italy
- 8.4.7.1. Italy: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.8. Diet Pills Market - Spain
- 8.4.8.1. Spain: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.9. Diet Pills Market - Netherlands
- 8.4.9.1. Netherlands: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.4.10. Diet Pills Market - Russia
- 8.4.10.1. Russia: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5. Diet Pills Market - Asia Pacific
- 8.5.1. Asia Pacific: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5.4. Diet Pills Market - China
- 8.5.4.1. China: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.4.3. China: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5.5. Diet Pills Market - India
- 8.5.5.1. India: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.5.3. India: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5.6. Diet Pills Market - Malaysia
- 8.5.6.1. Malaysia: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5.7. Diet Pills Market - Japan
- 8.5.7.1. Japan: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5.8. Diet Pills Market - Indonesia
- 8.5.8.1. Indonesia: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.5.9. Diet Pills Market - South Korea
- 8.5.9.1. South Korea: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.6. Diet Pills Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.6.4. Diet Pills Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.6.5. Diet Pills Market - UAE
- 8.6.5.1. UAE: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.6.6. Diet Pills Market - Israel
- 8.6.6.1. Israel: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.6.7. Diet Pills Market - South Africa
- 8.6.7.1. South Africa: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.7. Diet Pills Market - Latin America
- 8.7.1. Latin America: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.3. Latin America: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.7.4. Diet Pills Market - Mexico
- 8.7.4.1. Mexico: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.7.5. Diet Pills Market - Brazil
- 8.7.5.1. Brazil: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Diet Pills Market, by Application, 2019-2032 (USD Million)
- 8.7.6. Diet Pills Market - Argentina
- 8.7.6.1. Argentina: Diet Pills Market, by Product Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Diet Pills Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Diet Pills Market, by Application, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Arena Pharmaceuticals
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Currax Pharmaceuticals
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Chong's Health Care
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Cortislim
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Gelesis Inc
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. GlaxoSmithKline Pharmaceuticals
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Lovate Health Sciences
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Novo Nordisk
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Nanjing Chang'ao Pharmaceutical
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Orexigen Therapeutics
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Pfizer Inc
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. TEVA Pharmaceutical
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Vivus, Inc
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Zoller Laboratories
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
